Keith Barclay

Chief Investment Officer at CALEDONIAN HOLDINGS PLC

Finance

Consumer Services

Health Technology

Profile

Keith Barclay currently works at Caledonian Holdings Plc, as Investment Director from 2025.
Mr. Barclay also formerly worked at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Senior Investor from 2015 to 2024.
Mr. Barclay received his graduate degree from the University of Aberdeen.

Keith Barclay active positions

Companies	Position	Start
CALEDONIAN HOLDINGS PLC	Chief Investment Officer	2025-07-31

All active positions of Keith Barclay

Former positions of Keith Barclay

Companies	Position	End
Business Growth Fund Ltd Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments.	Private Equity Investor	2023-12-31
Elasmogen Ltd. Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases	Chief Investment Officer	-

See the detail of Keith Barclay's experience

Training of Keith Barclay

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Barclay's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Vela Technologies Plc Vela Technologies Plc Financial ConglomeratesFinance Operates as an investment company	Finance
University of Aberdeen University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Business Growth Fund Ltd Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments.	Finance
Elasmogen Ltd. Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases	Health Technology